Events Calendar


Digital Event
/Portals/0/NADevEventsImages/OSP Digital BioTuesday - 3 Nov 2020_800.png

Digital BioTuesday: 'An Insight to the Role of Biobanks in Life Sciences R&D Innovation'

Event Start Date: 03/11/2020 17:00

Event End Date: 03/11/2020 19:00

Sign Up To This Event
There are currently 100 spaces left.

Digital BioTuesday:
 

‘An Insight into the Role of Biobanks in Life Sciences R&D Innovation’
 

Kindly hosted by The Oxford Science Park

 


This BioTuesday event will bring together experts from across the biobanking industry, to share an update on how biobanks have evolved, common goals between partners and the potential impact on future research. 



Biobanks have become a critical resource in medical research and play a crucial role in facilitating access to tissue, blood samples, DNA and data that have helped scientists evolve their understanding of human health and a wide range of serious and life-threatening illnesses.  Events such as the Covid-19 pandemic make the need for such resources very clear. 


Through prolonged research and study, biobanking has helped produce treatments for specific diseases including cancer, heart diseases, stroke, diabetes, arthritis, osteoporosis, eye disorders, depression, and forms of dementia.



Areas to be addressed:


•             An insight into the work of UK Biobank, the national and international resource funded by the MRC and the Wellcome Trust


•             The role of biobanks during the COVID-19 pandemic, from both an epidemiology and treatment perspective


•             The role of the UK Clinical Research Collaboration (UKCRC) Partner, in supporting collaboration in the UK clinical research environment


•             The role of the Health Research Authority and the Research Ethics Committees in ensuring the ethical and regulatory compliance of biobanks in the UK, particularly around consent, handling, and future access to samples


•             Advice for researchers planning to work with a biobank, what ethical approval they may need and what barriers they may face?


•             Insight into virtual biobanks, developed to assist investigators in locating biospecimens for testing and data mining from multiple biobanks in dispersed locations


•             The role that the NHS play in recruiting patients to join study cohorts, and the benefit this offers to UK Biobanks




Agenda:


17:00 - Welcome


          Emma Palmer-Foster, Strategic Communications Consultant at The Oxford Science Park


17:05 - Keynote 1


          Naomi Allen, Professor of Epidemiology at Nuffield Department of Population Health, University of Oxford


17:25 - Keynote 2


          Catherine Blewett, Senior Development Manager, HRA, NHS


17:45 - Case Study 1


          Morag McFarlane, CEO, & Fiona MacKenzie, Client Services Director, at Tissue Solutions


18:05 - Case Study 2

          TBC

18:15 - Audience Q&A
 

18:30 - Networking
 

About the event:


This session will be run in a live format, with registration open for both OBN Members and Non-Members.  

A live Q&A will follow the keynote presentations and audience members will be encouraged to engage with hosts regarding their thoughts on the topic, and any personal experiences.

There will also be an opportunity to network with registered delegates after the Q&A with OBN's virtual networking platform - Remo. Details will be sent upon registration.

OBN Members - Complimentary

Non-Members - £25+VAT


 

 

This digital event is kindly hosted by:

The Oxford Science Park is one of the most influential science, technology and business environments in the UK for more than 2,500 people in over 70 companies, ranging from start-ups to SMEs and multi-national organisations. It was created in 1991 and is owned and managed by Magdalen College Oxford, one of Oxford’s oldest and most famous colleges with a tradition of academic excellence and entrepreneurship. The Park continues to uphold the College’s heritage. People who work here enjoy 75 acres of beautifully landscaped grounds and an atmosphere of discovery, innovation and entrepreneurship.

Return